* OPTIFAST® patients who actively participate in a 26-week medically-monitored program typically lose approximately 30 lbs.
In studies, over 50% of patients maintained their weight loss after 5 years! 5
The OPTIFAST® Program is based on the use of meal replacements during the Active Weight Loss phase of the program.
Simple and effective, OPTIFAST® meal replacements allow you to benefit from:
Positive change can occur very quickly. In addition to losing weight, you will improve your health; learn new, healthier eating habits; and engage in activities so that when you return to self-prepared foods, you are better equipped to manage your weight long term.
The Core Program is typically 6 months but can vary depending on each patients unique needs. This will be discussed with you during your initial consultation.
All appointments with physicians are covered by OHIP. However, the OPTIFAST® meal replacement program is not and can be purchased for a reasonable price. In many cases, these expenses can be covered by extended benefits and health savings accounts
This will be assessed during your initial consultation with your physician. Generally speaking patients whose BMI is greater than 30 or BMI greater than 27 and less than 30 but with obesity related health issues will qualify.
We encourage you to discuss your weight loss goals with your family doctor, however, it is not required to have a referral.
2250 Suite # 303, Bovaird Drive East, Brampton, ON L6R 0W3.
Phone: +1 (905) 792-6223
Fax: +1 (866) 233-9346
1 Ard JD, Lewis KH, Rothberg A, et al. Effectiveness of a total meal replacement program (OPTIFAST® program) on weight loss: results from the OPTIWIN study. Obesity. 2018; doi: 10.1002/oby.22303.
2 Ard JD, Schroeder MC, Kivilaid K, et al. Practical application of a comprehensive weight management program in patients with and without metabolic syndrome. J Obes Weight Loss Ther. 2014;S4:007.
3 Wadden TA, Foster GD, Letizia KA, Stunkard AJ. A multicenter evaluation of a proprietary weight reduction program for the treatment of marked obesity. Arch Intern Med. 1992;152(5):961-966.
4 Drawert S, Bedford K, Largent D. Change in glucose, blood pressure, and cholesterol with weight loss in medically obese patients. Obes Res. 1996;4(Suppl 1):67S.
5 Wadden TA, et al. A multicenter evaluation of a proprietary weight loss program for the treatment of marked obesity: A five year follow-up. Int J East Disord. 1997; 22:203-212.